Results 181 to 190 of about 15,663,299 (319)

Molecular techniques to interrogate and edit the Chlamydomonas nuclear genome.

The Plant Journal, 2015
Robert E. Jinkerson, M. Jonikas
semanticscholar   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source

Molecular techniques v. conventional culture: Should there really be a debate? [PDF]

Afr J Thorac Crit Care Med
Maasdorp SD, van der Westhuizen B.
europepmc   +1 more source

Retracted: The Application of Molecular Techniques for Assessment of SOX2 and miR126 Expression as Prognostic Markers in Esophageal Carcinoma. [PDF]

Comput Math Methods Med, 2022
Methods In Medicine CAM.
europepmc   +1 more source

Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques

Journal of Perinatal Medicine, 2015
R. Romero, J. Miranda, J. Kusanovic, T. Chaiworapongsa, P. Chaemsaithong, Alicia Martínez, F. Gotsch, Zhong Dong, A. Ahmed, Majid Shaman, Kia Lannaman, B. Yoon, S. Hassan, C. Kim, S. Korzeniewski, L. Yeo, Y. M. Kim   +16 more
semanticscholar   +1 more source

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Detection of rifampin-resistant Mycobacterium tuberculosis using CRISPR/Cas14a-enabled molecular techniques. [PDF]

BMC Infect Dis
Wu G, Ren Y, Wang Y, Zhao Y, Wu Y, Sun H, Sun Z, Wang R, Du Z.   +8 more
europepmc   +1 more source

Prevalence of Plasmodium Falciparum Gametocytes among Malaria Positive Cases at Korogwe District Hospital: The Use of Molecular Techniques in Comparison with Light Microscopy. [PDF]

Rwanda J Med Health Sci, 2023
Urassa AP, Kudra MP, Kaaya RD, Kajeguka DC, Mkumbaye SI.   +4 more
europepmc   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Comprehensive and translational pathobiology of COVID-19 based on cellular and molecular techniques. [PDF]

Pract Lab Med
Samadani AA, Vahidi S, Babaei K, Norollahi SE, Delpasand K, Gharakhyli EA.   +5 more
europepmc   +1 more source